Sort
48,018 grants matching “immunotherapy”
Defining the T-cell Response to Human Renal Cancer
$1,252,404James C Yang · Clinical Sciences · Z01 · FY2007 · CA
Immunophysiological Mechanisms in the Biological Therapy of Cancer
$1,252,261Robert Wiltrout · Basic Sciences · Z01 · FY2007 · CA
Autonomic Disorders Programs Project
$1,252,124Phillip A Low · Mayo Clinic Rochester · P50 · FY2009 · NS
Depletion, Repopulation and Tolerance in Sensitized Recipients
$1,251,943Stuart Johnston Knechtle · Duke University · U19 · FY2020 · AI
Neuroimmune responses and therapeutics of alpha-synucleinopathies of the aging population
$1,250,974Eliezer Masliah · National Institute On Aging · ZIA · FY2018 · AG
Basis for Success of Multidrug-Resistant Enterobacteriaceae
$1,250,736Frank Deleo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Novel immunotherapeutics against multidrug-resistant Neisseria gonorrhoea
$1,250,425Sanjay Ram · Univ Of Massachusetts Med Sch Worcester · R01 · FY2017 · AI
Regulation of epithelial cell fate decisions in tissue homeostasis and cancer
$1,250,210Ramiro Iglesias-Bartolome · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
SBIR Phase II: Engineered Induced Thymic Epithelial Cells for Novel T Cell Immunotherapies
$1,250,000Hui Gai · Rattan Life Science Inc. · · FY2025 · TIP
Clinical and Translational Science Award
$1,250,000Reza Shaker · Medical College Of Wisconsin · UL1 · FY2021 · TR
VICKtOrY Early Clinical Trials Consortium
$1,249,062Patricia M Lorusso · Yale University · UM1 · FY2025 · CA
LOS ANGELES PEDIATRIC AIDS CONSORTIUM
$1,248,584University Of California Los Angeles · U01 · FY2000 · AI
GENETIC APPROACHES FOR CANCER IMMUNOTHERAPY
$1,248,539University Of Michigan At Ann Arbor · P01 · FY2000 · CA
The effect of peptide therapy and allergen provocation on Fel d1-specific T Cells
$1,248,202Mark Larche · Mcmaster University · U19 · FY2013 · AI
Innate inflammatory responses during pulmonary infections
$1,247,742Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
TARGETING THE GENETIC DETERMINANTS OF IMMUNE ESCAPE AND IMMUNOTHERAPY FAILURE IN CRPC
$1,247,724University Of Massachusetts Medical School · · FY2022 · Defense Health Agency
Epigenetic Therapy for Thoracic Malignancies
$1,247,492David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2024 · CA
Search for the Structural Basis of Biomacromolecular Function and Activity
$1,247,302Yun Xing M Wang · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
IMPROVING CORD BLOOD TRANSPLANTATION
$1,247,007Elizabeth J Shpall · University Of Tx Md Anderson Can Ctr · P01 · FY2016 · CA
American Trial Using Tranexamic Acid in Thrombocytopenia (A-TREAT)
$1,246,011Terry B Gernsheimer · University Of Washington · U01 · FY2015 · HL
Single-cell DNA methylation analysis of human cancer
$1,244,669Kenneth Aldape · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Autonomic Disorders Programs Project
$1,242,949Phillip A Low · Mayo Clinic Rochester · P50 · FY2008 · NS
Innate inflammatory responses during pulmonary infections
$1,242,800Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
ADULT AIDS CLINICAL TRIAL UNIT
$1,241,833University Of Texas Medical Br Galveston · U01 · FY2004 · AI
Epstein-Barr Virus Associated Disorders
$1,241,754Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI